XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Premiums $ 11,603 $ 11,025
Net investment income 290 277
TOTAL REVENUES 57,255 46,517 Close
Benefits and expenses    
Pharmacy and other service costs 41,431 31,459
Medical costs and other benefit expenses 9,440 9,046
Selling, general and administrative expenses 3,705 3,538
Amortization of acquired intangible assets 423 459
TOTAL BENEFITS AND EXPENSES 54,999 44,502 Close
Income from operations 2,256 2,015 Close
Interest expense and other (322) (358) Close
Loss on sale of businesses (19) 0 Close
Net realized investment losses (1,836) (56) Close
Total Other Income Expenses -2177.0 -414.0 0 0 0 Close
Income before income taxes 79 1,601 CloseClose
TOTAL INCOME TAXES 291 295 Close
Net (loss) income (212) 1,306 Close
Less: Net income attributable to noncontrolling interests 65 39
SHAREHOLDERS' NET (LOSS) INCOME $ (277) $ 1,267
Shareholders' net (loss) income per share    
Basic (in dollars per share) $ (0.97) $ 4.28
Diluted (in dollars per share) $ (0.97) $ 4.24
Pharmacy revenues    
Revenues    
Revenues $ 42,036 $ 32,144
Fees and other revenues    
Revenues    
Revenues $ 3,326 $ 3,071